Clinical Trials Logo

Clinical Trial Summary

This study aims to constitute a collection of biological materials from in transplant patients and to provide biological materials from transplanted patients in order : i) validate new theory on the cause of allograft loss, ii) develop innovative biomarker for rejection and other transplantation-related conditions (such as BK virus nephropathy, Post-transplant lymphoproliferative disorder ( PTLD) ...)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04687865
Study type Observational
Source Hospices Civils de Lyon
Contact Olivier Thaunat, MD
Phone 04 72 11 69 28
Email olivier.thaunat@chu-lyon.fr
Status Recruiting
Phase
Start date January 8, 2020
Completion date January 8, 2040

See also
  Status Clinical Trial Phase
Recruiting NCT00987103 - Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients Phase 1
Completed NCT03699839 - Reducing the Burden of Influenza After Solid-Organ Transplantation Phase 2/Phase 3
Completed NCT01633424 - The "Stanford Integrated Psychosocial Assessment for Transplant" (SIPAT)
Completed NCT01254955 - Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients N/A
Completed NCT00948883 - Study of Cancers After Solid Organs Transplants N/A
Recruiting NCT02314949 - Leuven Tolerogenic Protocol for Intestinal Transplantation N/A
Recruiting NCT01283295 - Immune Monitoring and Assay Development in Organ Transplant Recipients
Not yet recruiting NCT03861962 - Re-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen Level to Epitope Level
Completed NCT01123187 - Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation N/A
Completed NCT00213304 - The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation Phase 3
Completed NCT01515072 - Remote Ischemic Preconditioning in Neurological Death Organ Donors N/A
Completed NCT00904579 - Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
Recruiting NCT00611494 - Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors Phase 4
Completed NCT02852902 - Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
Completed NCT05685888 - Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transplantation
Recruiting NCT00792064 - Systematic Evaluation of Predictors of Quality of Life in the Long-term After Solid Organ Transplantation N/A
Completed NCT00734396 - Mesenchymal Stem Cells and Subclinical Rejection Phase 1/Phase 2
Completed NCT00286871 - Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen Phase 1
Recruiting NCT03997253 - Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management N/A
Recruiting NCT01256931 - Antibody Levels Against 2009 Influenza A H1N1 One Year After Vaccination With Pandemrix and 2010 Fluarix Booster in Organ Transplant Recipients. N/A